Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Intangibles (2024)

Historic Change in Intangibles for Anika Therapeutics (ANIK) over the last 1 years, with Q3 2024 value amounting to $600000.0.

  • Anika Therapeutics' Change in Intangibles changed N/A to $600000.0 in Q3 2024 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year change of. This contributed to the annual value of $600000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Anika Therapeutics reported Change in Intangibles of $600000.0 as of Q3 2024.
  • Anika Therapeutics' Change in Intangibles' 5-year high stood at $600000.0 during Q3 2024, with a 5-year trough of $600000.0 in Q3 2024.